EIND Applications for Antiviral Products

by Pill Pals Customer Service | Aug 8, 2025 | News

Note: The following information is to be used by physicians who would like to request an Emergency IND for an antiviral product regulated by the Center for Drug Evaluation and Research (CDER)/Division of Antivirals (DAV). DAV regulates products that are being...

Ananeoo Wellness LLC – Online Advisory Letter

by Pill Pals Customer Service | Aug 8, 2025 | News

Online Advisory Letter Reference # 703111June 17, 2025Ananeoo Wellness LLC1785 South Patrick Dr.Indian Harbour Beach, FL 32937CustomerCare@ananeoo.comRE: Ananeoo Cellular Nutrition & DetoxificationDear Ananeoo Wellness LLC:This letter is to advise you that...

President’s Emergency Plan for AIDS Relief (PEPFAR)

by Pill Pals Customer Service | Aug 7, 2025 | News

Explore the PEPFAR Interactive DatabaseSearch for information about tentatively approved and approved antiretroviral drugs that are eligible for procurement under the President’s Emergency Plan for AIDS Relief (PEPFAR) Program. Information for IndustryLearn about the...

FDA’s Actions to Address Unapproved Thyroid Medications

by Pill Pals Customer Service | Aug 7, 2025 | News

Medications for treatment of hypothyroidismHypothyroidism is a condition of decreased thyroid hormone production from the thyroid gland, which affects about 2% of the adult population in the United States. Millions of Americans take thyroid hormone replacement...

FDA Actions to Remove Unapproved Drugs from the Market by Drug

by Pill Pals Customer Service | Aug 7, 2025 | News

Animal-derived thyroid productAscorbic acid injectionCocaine hydrochloride solution productsDehydrated alcoholIodoquinol DrugsIsometheptene-containing drugsIsoxsuprineLocal anestheticsMeperidine hydrochloride and promethazine hydrochloride drugsNonsteroidal...

FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live)

by Pill Pals Customer Service | Aug 7, 2025 | News

AUDIENCE: Patient, Health Care Professional, Pharmacy, Cardiology, Neurology, Internal Medicine, Family Practice, Travel ClinicsISSUE: On May 9, 2025, FDA issued a safety communication informing the public that the Food and Drug Administration (FDA) and the Centers...